AGEN
Agenus Inc
NASDAQ: AGEN · HEALTHCARE · BIOTECHNOLOGY
$3.84
-1.29% today
Updated 2026-04-29
Market cap
$147.45M
P/E ratio
0.00
P/S ratio
1.29x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$3 – $7
Volume
0.8M
Agenus Inc (AGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.10%
Operating margin
42.10%
ROE
-1,279.00%
ROA
-5.67%
Debt/equity
-0.17x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $692135.00 | $-51.88M | 100.00% | -7,312.63% | -7,495.73% |
| 2007 | $5.55M | $-36.80M | 100.00% | -599.35% | -662.70% |
| 2008 | $2.65M | $-28.70M | 100.00% | -1,427.48% | -1,082.49% |
| 2009 | $3.33M | $-30.32M | 100.00% | -830.19% | -909.36% |
| 2010 | $3.36M | $-21.91M | 96.34% | -647.47% | -652.05% |
| 2011 | $2.76M | $-23.28M | 100.00% | -692.61% | -844.63% |
| 2012 | $15.96M | $-11.32M | 29.60% | -42.23% | -70.95% |
| 2013 | $3.04M | $-30.07M | -344.70% | -820.36% | -987.62% |
| 2014 | $6.98M | $-42.49M | -220.32% | -620.91% | -608.94% |
| 2015 | $24.82M | $-87.88M | -183.85% | -325.18% | -354.12% |
| 2016 | $22.57M | $-127.00M | -320.73% | -476.13% | -562.60% |
| 2017 | $42.88M | $-120.69M | -170.83% | -242.09% | -281.48% |
| 2018 | $36.78M | $-159.69M | -238.74% | -336.62% | -434.14% |
| 2019 | $150.05M | $-107.66M | -12.19% | -46.74% | -71.75% |
| 2020 | $88.17M | $-180.91M | -64.42% | -132.96% | -205.19% |
| 2021 | $295.67M | $-23.93M | 38.42% | 8.71% | -8.09% |
| 2022 | $98.02M | $-220.07M | -101.24% | -183.04% | -224.51% |
| 2023 | $156.31M | $-245.76M | -52.05% | -102.07% | -157.22% |
| 2024 | $103.46M | $-227.21M | -50.79% | -116.44% | -219.61% |
| 2025 | $114.20M | $115000.00 | 90.35% | -18.00% | 0.10% |